Cohen Milstein Urges Shareholders Who Lost Significant Money in Paragon 28, Inc. to Contact Firm
A class action securities lawsuit has been filed against Paragon 28 (NYSE:FNA), a medical device company, in the U.S. District Court for the District of Colorado. The lawsuit alleges that the company and certain officers made false and misleading statements regarding financial statements and internal controls between May 5, 2023 and September 20, 2024. Cohen Milstein Sellers & Toll PLLC is urging affected shareholders who suffered significant losses during this period to contact them by November 29, 2024 to potentially serve as lead plaintiff. Investors are not required to file as lead plaintiff to participate in any potential recovery.
È stata intentata una causa collettiva in materia di titoli contro Paragon 28 (NYSE:FNA), un'azienda di dispositivi medici, presso il tribunale distrettuale degli Stati Uniti per il distretto del Colorado. La causa sostiene che l'azienda e alcuni dirigenti hanno rilasciato dichiarazioni false e fuorvianti riguardo ai bilanci e ai controlli interni tra il 5 maggio 2023 e il 20 settembre 2024. Cohen Milstein Sellers & Toll PLLC invita gli azionisti colpiti che hanno subito perdite significative durante questo periodo a contattarli entro il 29 novembre 2024 per essere considerati come potenziali attori principali. Non è necessario essere co-plaintiff per partecipare a eventuali recuperi.
Se ha presentado una demanda colectiva de valores contra Paragon 28 (NYSE:FNA), una empresa de dispositivos médicos, en el Tribunal de Distrito de los Estados Unidos para el Distrito de Colorado. La demanda alega que la empresa y ciertos funcionarios hicieron declaraciones falsas y engañosas sobre los estados financieros y los controles internos entre el 5 de mayo de 2023 y el 20 de septiembre de 2024. Cohen Milstein Sellers & Toll PLLC está instando a los accionistas afectados que sufrieron pérdidas significativas durante este período a contactarlos antes del 29 de noviembre de 2024 para considerar la posibilidad de ser demandantes principales. No se requiere que los inversionistas se presenten como demandantes principales para participar en cualquier recuperación potencial.
미국 콜로라도 지방법원에 Paragon 28 (NYSE:FNA), 의료기기 회사에 대한 집단 소송이 제기되었습니다. 이 소송은 회사와 특정 임원들이 2023년 5월 5일부터 2024년 9월 20일 사이에 재무 제표 및 내부 통제에 대해 잘못된 및 오해의 소지가 있는 진술을 했다고 주장하고 있습니다. Cohen Milstein Sellers & Toll PLLC는 이 기간 동안 상당한 손실을 입은 영향을 받은 주주들에게 2024년 11월 29일까지 연락해 주기를 권장하고 있습니다. 투자자들은 잠재적인 회복에 참여하기 위해 반드시 주된 원고로 출원할 필요는 없습니다.
Une action collective en valeurs mobilières a été déposée contre Paragon 28 (NYSE:FNA), une entreprise de dispositifs médicaux, devant le tribunal de district des États-Unis pour le district du Colorado. La plainte allègue que l'entreprise et certains dirigeants ont fait des déclarations fausses et trompeuses concernant les états financiers et les contrôles internes entre le 5 mai 2023 et le 20 septembre 2024. Cohen Milstein Sellers & Toll PLLC invite les actionnaires concernés qui ont subi d'importantes pertes pendant cette période à les contacter d'ici le 29 novembre 2024 pour éventuellement agir en tant que plaintiffs principaux. Les investisseurs ne sont pas tenus de se porter candidats comme plaintiffs principaux pour participer à tout éventuel recouvrement.
Es wurde eine Sammelklage gegen Paragon 28 (NYSE:FNA), ein Unternehmen für medizinische Geräte, beim US-Bezirksgericht für den Bezirk Colorado eingereicht. Die Klage behauptet, dass das Unternehmen und bestimmte Führungskräfte zwischen dem 5. Mai 2023 und dem 20. September 2024 falsche und irreführende Aussagen zu den Finanzberichten und internen Kontrollen gemacht haben. Cohen Milstein Sellers & Toll PLLC fordert betroffene Aktionäre, die in diesem Zeitraum erhebliche Verluste erlitten haben, auf, sich bis spätestens 29. November 2024 an sie zu wenden, um möglicherweise als Kläger aufzutreten. Investoren sind nicht verpflichtet, als Hauptkläger aufzutreten, um an einer möglichen Wiederherstellung teilzunehmen.
- None.
- Company faces class action lawsuit for alleged false and misleading financial statements
- Potential securities fraud allegations regarding internal controls
- Legal proceedings may result in financial penalties and reputational damage
Insights
This securities class action lawsuit against Paragon 28 signals potentially serious allegations of financial misrepresentation and internal control issues. The complaint filed in Colorado District Court alleges violations of key securities laws between May 2023 and September 2024, specifically Sections 10(b) and 20(a) of the Securities Exchange Act. These sections deal with securities fraud and controlling person liability.
The involvement of Cohen Milstein, a prominent securities litigation firm with a track record of significant recoveries (including a
WASHINGTON, DC / ACCESSWIRE / November 12, 2024 / Investors who lost money on securities of Paragon 28, Inc. ("Paragon 28" or the "Company") (NYSE:FNA) purchased between May 5, 2023 and September 20, 2024 can contact Cohen Milstein Sellers & Toll PLLC to learn about a new class action securities lawsuit.
To learn about your legal options, click here to hear from member of the Cohen Milstein team or contact Partner Molly J. Bowen at (202) 408-4600 or mbowen@cohenmilstein.com.
CASE BACKGROUND: Paragon 28 is a medical device company. A complaint filed on October 18, 2024 in the U.S. District Court for the District of Colorado alleges that the Company and certain current and former officers made false and misleading statements to investors about financial statements and internal controls in violation of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934.
NEXT STEPS: If you suffered a significant loss in Paragon 28 shares purchased during the proposed class period, between May 5, 2023 to September 20, 2024, and are interested in serving as lead plaintiff in this action, you have until November 29, 2024 to request that the court appoint you as lead plaintiff. You are not required to file a lead plaintiff motion to share in any recovery in this action as a class member.
OUR FIRM: With more than 100 attorneys in eight offices, Cohen Milstein is one of the largest plaintiff-side law firms in the U.S., with more than four decades of experience litigating securities fraud cases. We have recovered billions of dollars to investors, including
Prior results do not guarantee a similar outcome. This may be considered Attorney Advertising.
CONTACT INFORMATION:
Molly Bowen, Esq.
Licensed in DC, Florida, and Ohio
Cohen Milstein Sellers & Toll PLLC
1100 New York Avenue, N.W., Fifth Floor
Washington, D.C. 20005
Telephone: (888) 240-0775 or (202) 408-4600
Email: mbowen@cohenmilstein.com
Website: www.cohenmilstein.com
SOURCE: Cohen Milstein Sellers & Toll PLLC
View the original press release on accesswire.com
FAQ
What is the deadline to join the Paragon 28 (FNA) class action lawsuit?
What period does the Paragon 28 (FNA) class action lawsuit cover?
What are the allegations against Paragon 28 (FNA) in the lawsuit?
